US Patent Issued to Celgene on May 12 for "Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases" (New Jersey, California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,003, issued on May 12, was assigned to Celgene Corp. (Princeton, N.J.).

"Carboxylic acid containing indanyl compounds for the treatment of neurodegenerative diseases" was invented by Jeffrey M. Schkeryantz (Summit, N.J.), Julie Selkirk (Summit, N.J.), Philip Stewart Turnbull (San Diego), Junko Tamiya (Carlsbad, Calif.), Patrick W. Papa (Carlsbad, Calif.), Jean-Francois Brazeau (San Diego) and Karin Worm (Summit, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases."

The pat...